Literature DB >> 14534298

Beta-arrestin1 mediates insulin-like growth factor 1 (IGF-1) activation of phosphatidylinositol 3-kinase (PI3K) and anti-apoptosis.

Thomas J Povsic1, Trudy A Kohout, Robert J Lefkowitz.   

Abstract

beta-arrestins (1 and 2) are widely expressed cytosolic proteins that play central roles in G protein-coupled receptor signaling. beta-arrestin1 is also recruited to the insulin-like growth factor 1 (IGF-1) receptor, a receptor tyrosine kinase, upon agonist binding. Here we report that, in response to IGF-1 stimulation, beta-arrestin1 mediates activation of phosphatidylinositol 3-kinase in a pathway that leads to the subsequent activation of Akt and anti-apoptosis. This process is independent of both Gi and ERK activity. The pathway fails in mouse embryo fibroblasts lacking both beta-arrestins and is restored by stable transfection of beta-arrestin1. Remarkably, this pathway is insensitive to chemical inhibition of IGF-1 receptor tyrosine kinase activity. These results suggest that, in addition to their roles in G protein-coupled receptor signaling, beta-arrestins couple the IGF-1 receptor tyrosine kinase to the phosphatidylinositol 3-kinase system and suggest that this mechanism is operative independently of the tyrosine kinase activity of the receptor.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14534298     DOI: 10.1074/jbc.M309968200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  67 in total

1.  beta-Arrestin inhibits NF-kappaB activity by means of its interaction with the NF-kappaB inhibitor IkappaBalpha.

Authors:  D Scott Witherow; Tiffany Runyan Garrison; William E Miller; Robert J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-01       Impact factor: 11.205

2.  Engagement of β-arrestin by transactivated insulin-like growth factor receptor is needed for V2 vasopressin receptor-stimulated ERK1/2 activation.

Authors:  Geneviève Oligny-Longpré; Maithé Corbani; Joris Zhou; Mireille Hogue; Gilles Guillon; Michel Bouvier
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-09       Impact factor: 11.205

Review 3.  β-Arrestins: multifunctional signaling adaptors in type 2 diabetes.

Authors:  Xiaotao Feng; Wenjian Wang; Jibo Liu; Yi Liu
Journal:  Mol Biol Rep       Date:  2010-11-18       Impact factor: 2.316

Review 4.  β-Arrestins 1 and 2 are critical regulators of inflammation.

Authors:  Hongkuan Fan
Journal:  Innate Immun       Date:  2013-09-12       Impact factor: 2.680

Review 5.  Beta-arrestins and heterotrimeric G-proteins: collaborators and competitors in signal transduction.

Authors:  K Defea
Journal:  Br J Pharmacol       Date:  2007-11-26       Impact factor: 8.739

6.  Beta-arrestin-mediated signaling regulates protein synthesis.

Authors:  Scott M DeWire; Jihee Kim; Erin J Whalen; Seungkirl Ahn; Minyong Chen; Robert J Lefkowitz
Journal:  J Biol Chem       Date:  2008-02-14       Impact factor: 5.157

7.  The 27-kDa heat shock protein confers cytoprotective effects through a beta 2-adrenergic receptor agonist-initiated complex with beta-arrestin.

Authors:  Lalida Rojanathammanee; Erin B Harmon; Laurel A Grisanti; Piyarat Govitrapong; Manuchair Ebadi; Bryon D Grove; Masaru Miyagi; James E Porter
Journal:  Mol Pharmacol       Date:  2009-01-27       Impact factor: 4.436

Review 8.  Insulin-like Growth Factor-I Receptor and Thyroid-Associated Ophthalmopathy.

Authors:  Terry J Smith; Joseph A M J L Janssen
Journal:  Endocr Rev       Date:  2019-02-01       Impact factor: 19.871

Review 9.  The emerging roles of β-arrestins in fibrotic diseases.

Authors:  Yuan-jing Gu; Wu-yi Sun; Sen Zhang; Jing-jing Wu; Wei Wei
Journal:  Acta Pharmacol Sin       Date:  2015-09-21       Impact factor: 6.150

10.  Akt and ERK1/2 pathways are components of the vasopressin signaling network in rat native IMCD.

Authors:  Trairak Pisitkun; Vinitha Jacob; Stephen M Schleicher; Chung-Lin Chou; Ming-Jiun Yu; Mark A Knepper
Journal:  Am J Physiol Renal Physiol       Date:  2008-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.